As expected, the results of in vitro experiments indicated that AIP4 co-expression significantly suppressed the TP53-deletion prostate cancer cells migration rate, chemotaxis, and attachment toward the osteoblasts (Figures 5A–C). Here, TP53 is linked to prostate carcinoma.